Transforming the Information System for Research in Primary Care (SIDIAP) in Catalonia to the OMOP Common Data Model and Its Use for COVID-19 Research

References

• Roser M, Ortiz-Ospina E. Spain: what is the daily number of confirmed deaths? Available from: OurWorldInData.org; Accessed January 23, 2023.
   Google Scholar
• Gérvas J, Pérez Fernández M, Starfield BH. Primary care, financing and gatekeeping in Western Europe. Fam Pract. 1994;11(3):307–317. doi:10.1093/fampra/11.3.307
   PubMed Web of Science ®Google Scholar
• Borras-Bermejo B, Martínez-Gómez X, Gutierrez-San Miguel M, et al. Asymptomatic SARS-CoV-2 infection in nursing homes, Barcelona, Spain, April 2020. Emerg Infect Dis. 2020;26(9):2281–2283. doi:10.3201/eid2609.202603
   PubMed Web of Science ®Google Scholar
• Mathieu E, Ritchie H, Ortiz-Ospina E, et al. What share of the population has received at least one dose of vaccine?. Available from: OurWorldInData.org; Accessed January 23, 2020.
   Google Scholar
• Recalde M, Rodríguez C, Burn E, et al. Data resource profile: the information system for research in primary care (SIDIAP). Int J Epidemiol. 2022;51(6):e324–e336. doi:10.1093/ije/dyac068
   PubMed Web of Science ®Google Scholar
• Ramos R, Comas-Cufí M, Martí-Lluch R, et al. Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study. BMJ. 2018;362:k3359. doi:10.1136/bmj.k3359
   PubMedGoogle Scholar
• Alexander M, Loomis AK, van der Lei J, et al. Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults. BMJ. 2019;367. doi:10.1136/bmj.l5367
   PubMedGoogle Scholar
• Burn E, Murray DW, Hawker GA, Pinedo-Villanueva R, Prieto-Alhambra D. Lifetime risk of knee and Hip replacement following a GP diagnosis of osteoarthritis: a real-world cohort study. Osteoarthritis and Cartilage. 2019;27:1627–1635. doi:10.1016/j.joca.2019.06.004
   PubMed Web of Science ®Google Scholar
• Prieto-Alhambra D, Balló E, Coma E, et al. Filling the gaps in the characterization of the clinical management of COVID-19: 30-day hospital admission and fatality rates in a cohort of 118 150 cases diagnosed in outpatient settings in Spain. Int J Epidemiol. 2021;49(6):1930–1939. doi:10.1093/ije/dyaa190
   PubMed Web of Science ®Google Scholar
• Hripcsak G, Duke JD, Shah NH, et al. Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574–578.
   PubMedGoogle Scholar
• Voss EA, Makadia R, Matcho A, et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015;22:553–564. doi:10.1093/jamia/ocu023
   PubMed Web of Science ®Google Scholar
• Datta S, Posada J, Olson G, et al. A new paradigm for accelerating clinical data science at Stanford medicine. arXiv. 2020. doi:10.48550/arXiv.2003.10534
   Google Scholar
• Junior EPP, Normando P, Flores-Ortiz R, et al. Integrating real-world data from Brazil and Pakistan into the OMOP common data model and standardized health analytics framework to characterize COVID-19 in the Global South. J Am Med Inform Assoc. 2022:ocac180. doi:10.1093/jamia/ocac180
   Web of Science ®Google Scholar
• Papez V, Moinat M, Voss EA, et al. Transforming and evaluating the UK Biobank to the OMOP common data model for COVID-19 research and beyond. J Am Med Inform Assoc. 2022;30(1):103–111. doi:10.1093/jamia/ocac203
   PubMed Web of Science ®Google Scholar
• Observational Health Data Sciences and Informatics. The Book of OHDSI. Independently published; 2019.
   Google Scholar
• Blacketer C, Defalco FJ, Ryan PB, Rijnbeek PR. Increasing trust in real-world evidence through evaluation of observational data quality. J Am Med Inform Assoc. 2021;28(10):2251–2257. doi:10.1093/jamia/ocab132
   PubMed Web of Science ®Google Scholar
• Golozar A, Lai LY, Sena AG, et al. Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United States. medRxiv. 2020;2020:1.
   Google Scholar
• Burn E, You SC, Sena AG, et al. Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nat Commun. 2020;11(1):5009. doi:10.1038/s41467-020-18849-z
   PubMed Web of Science ®Google Scholar
• Duarte-Salles T, Vizcaya D, Pistillo A, et al. Thirty-day outcomes of children and adolescents with COVID-19: an international experience. Pediatrics. 2021;148(3):e2020042929. doi:10.1542/peds.2020-042929
   PubMed Web of Science ®Google Scholar
• Tan EH, Sena AG, Prats-Uribe A, et al. COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries. Rheumatology. 2021;60(SI):SI37–SI50. doi:10.1093/rheumatology/keab250
   PubMedGoogle Scholar
• Recalde M, Roel E, Pistillo A, et al. Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom. Int J Obes. 2021;45(11):2347–2357. doi:10.1038/s41366-021-00893-4
   Web of Science ®Google Scholar
• Reyes C, Pistillo A, Fernández-Bertolín S, et al. Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort study. BMJ Open. 2021;11(12):e057632. doi:10.1136/bmjopen-2021-057632
   PubMed Web of Science ®Google Scholar
• Roel E, Pistillo A, Recalde M, et al. Characteristics and outcomes of over 300,000 patients with COVID-19 and history of cancer in the United States and Spain. Cancer Epidemiol Biomarkers Prev. 2021;30(10):1884–1894. doi:10.1158/1055-9965.EPI-21-0266
   PubMed Web of Science ®Google Scholar
• Nishimura A, Xie J, Kostka K, et al. International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients. Front Pharmacol. 2022;13:945592. doi:10.3389/fphar.2022.945592
   PubMed Web of Science ®Google Scholar
• Morales DR, Conover MM, You SC, et al. Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis. Lancet Digit Health. 2021;3(2):e98–e114. doi:10.1016/S2589-7500(20)30289-2
   PubMedGoogle Scholar
• Williams RD, Markus AF, Yang C, et al. Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network. BMC Med Res Methodol. 2022;22(1):35. doi:10.1186/s12874-022-01505-z
   PubMed Web of Science ®Google Scholar
• Reps JM, Kim C, Williams RD, et al. Implementation of the COVID-19 vulnerability index across an international network of health care data sets: collaborative external validation study. JMIR Med Inform. 2021;9(4):e21547. doi:10.2196/21547
   PubMed Web of Science ®Google Scholar
• Li X, Ostropolets A, Makadia R, et al. Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study. BMJ. 2021;373:1435. doi:10.1136/bmj.n1435
   Google Scholar
• Burn E, Li X, Kostka K, et al. Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. Pharmacoepidemiol Drug Saf. 2022;31(5):495–510. doi:10.1002/pds.5419
   PubMed Web of Science ®Google Scholar
• Li X, Burn E, Duarte-Salles T, et al. Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US. BMJ. 2022;379:e071594. doi:10.1136/bmj-2022-071594
   PubMedGoogle Scholar
• Burn E, Duarte-Salles T, Fernandez-Bertolin S, et al. Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study. Lancet Infect Dis. 2022;22(8):1142–1152. doi:10.1016/S1473-3099(22)00223-7
   PubMed Web of Science ®Google Scholar
• Burn E, Roel E, Pistillo A, et al. Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in Catalonia, Spain. Nat Commun. 2022;13(1):7169. doi:10.1038/s41467-022-34669-9
   PubMed Web of Science ®Google Scholar
• Li X, Raventós B, Roel E, et al. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. BMJ. 2022;376:e068373. doi:10.1136/bmj-2021-068373
   PubMedGoogle Scholar
• Burn E, Tebé C, Fernandez-Bertolin S, et al. The natural history of symptomatic COVID-19 during the first wave in Catalonia. Nat Commun. 2021;12(1):777. doi:10.1038/s41467-021-21100-y
   PubMed Web of Science ®Google Scholar
• Roel E, Pistillo A, Recalde M, et al. Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: a population-based multistate cohort study including 4 618 377 adults in Catalonia, Spain. Int J Cancer. 2022;150(5):782–794. doi:10.1002/ijc.33846
   PubMed Web of Science ®Google Scholar
• Recalde M, Pistillo A, Fernandez-Bertolin S, et al. Body mass index and risk of COVID-19 diagnosis, hospitalization, and death: a cohort study of 2 524 926 catalans. J Clin Endocrinol Metab. 2021;106(12):e5030–e5042. doi:10.1210/clinem/dgab546
   PubMed Web of Science ®Google Scholar
• Raventós B, Abellan A, Pistillo A, Reyes C, Burn E, Duarte-Salles T. Impact of the COVID-19 pandemic on eating disorders diagnoses among adolescents and young adults in Catalonia: a population-based cohort study. Int J Eat Disord. 2023;56(1):225–234. doi:10.1002/eat.23848
   PubMed Web of Science ®Google Scholar
• Raventós B, Pistillo A, Reyes C, et al. Impact of the COVID-19 pandemic on diagnoses of common mental health disorders in adults in Catalonia, Spain: a population-based cohort study. BMJ Open. 2022;12(4):e057866. doi:10.1136/bmjopen-2021-057866
   PubMed Web of Science ®Google Scholar
• Roel E, Raventós B, Burn E, Pistillo A, Prieto-Alhambra D, Duarte-Salles T. Socioeconomic Inequalities in COVID-19 Vaccination and Infection in Adults, Catalonia, Spain. Emerg Infect Dis. 2022;28(11):2243–2252. doi:10.3201/eid2811.220614
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369. doi:10.1136/bmj.m1985
   PubMedGoogle Scholar
• Gupta S, Hayek SS, Wang W, et al. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med. 2020;180(11):1436–1447. doi:10.1001/jamainternmed.2020.3596
   PubMed Web of Science ®Google Scholar
• Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–436. doi:10.1038/s41586-020-2521-4
   PubMed Web of Science ®Google Scholar
• de Lusignan S, Dorward J, Correa A, et al. Risk factors for SARS-CoV-2 among patients in the oxford royal college of general practitioners research and surveillance centre primary care network: a cross-sectional study. Lancet Infect Dis. 2020;20(9):1034–1042. doi:10.1016/S1473-3099(20)30371-6
   PubMed Web of Science ®Google Scholar
• Ho FK, Celis-Morales CA, Gray SR, et al. Modifiable and non-modifiable risk factors for COVID-19, and comparison to risk factors for influenza and pneumonia: results from a UK Biobank prospective cohort study. BMJ Open. 2020;10(11):e040402. doi:10.1136/bmjopen-2020-040402
   PubMed Web of Science ®Google Scholar
• Qian J, Zhao L, Ye R-Z, Li X-J, Liu Y-L. Age-dependent gender differences of COVID-19 in mainland China: comparative study. Clin Infect Dis. 2020;71(9):2488–2494. doi:10.1093/cid/ciaa683
   PubMed Web of Science ®Google Scholar
• Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369. doi:10.1136/bmj.m1966
   PubMed Web of Science ®Google Scholar
• Generalitat de Catalunya. Salut/Dades COVID. Available from: dadescovid.cat. Accessed January 23, 2023.
   Google Scholar
• Griffith GJ, Morris TT, Tudball MJ, et al. Collider bias undermines our understanding of COVID-19 disease risk and severity. Nat Commun. 2020;11(1):5749. doi:10.1038/s41467-020-19478-2
   PubMed Web of Science ®Google Scholar
• Pham A, Cummings M, Lindeman C, Drummond N, Williamson T. Recognizing misclassification bias in research and medical practice. Fam Pract. 2019;36(6):804–807. doi:10.1093/fampra/cmy130
   PubMed Web of Science ®Google Scholar
• Grant MC, Geoghegan L, Arbyn M, et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systematic review and meta-analysis of 148 studies from 9 countries. PLoS One. 2020;15(6):e0234765. doi:10.1371/journal.pone.0234765
   PubMed Web of Science ®Google Scholar
• Menni C, Valdes AM, Freidin MB, et al. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med. 2020;26(7):1037–1040. doi:10.1038/s41591-020-0916-2
   PubMed Web of Science ®Google Scholar
• Kostka K, Duarte-Salles T, Prats-Uribe A, et al. Unraveling COVID-19: a large-scale characterization of 4.5 Million COVID-19 cases using CHARYBDIS. Clin Epidemiol. 2022;14:369–384. doi:10.2147/CLEP.S323292
   PubMed Web of Science ®Google Scholar